BASE BPA # HHSN261201700002B (BASE BPA period of performance: 8/1/17 - 7/31/19) master agreement terms and conditions apply. Support services (clinical program manager 5) for the office of sponsor &…
Ended Awarded Last action
- Contract number
- 75N91019F00148
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $500,563
Award facts
- Contract value 99% obligated
-
- $500,563.03 Current, with exercised options
- $505,563.03 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Red Bank, NJ, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,000 | |
| Funding Only Action | -$10,396 | |
| Funding Only Action | -$8,152 | |
| Funding Only Action | -$5,000 | |
| Funding Only Action | -$5,341 | |
| Exercise an Option | $182,448 | |
| Exercise an Option | $178,111 | |
| Original award | $173,894 |
About this award
The National Cancer Institute issued a BPA call to Astrix Technology LLC under the GSA Schedule Scientific Equipment and Services (FSS-66) on June 3, 2019, with a ceiling value of $505,563.03. The call supports clinical program management services for the Office of Sponsor & Regulatory Oversight at the National Cancer Institute's Center for Cancer Research, with a base period from June 3, 2019 through June 2, 2020 on a time-and-materials basis. Performance occurs in Red Bank, New Jersey. SCI reporting shows the call invoiced $166,000 in FY2021 across 0.9 FTEs and 1,879 contractor hours at a derived government-paid rate of $88.10 per hour, declining to $116,000 invoiced in FY2022 across 0.6 FTEs and 1,292 contractor hours at $89.62 per hour. Astrix self-performed all reported hours with no subcontractor involvement.
Description
BASE BPA # HHSN261201700002B (BASE BPA period of performance: 8/1/17 - 7/31/19) master agreement terms and conditions apply. Support services (clinical program manager 5) for the office of sponsor & regulatory oversight (OSRO), CCR, NCI - BASE period: 6/3/19 - 6/2/20 (SEVERABLE) time-and-materials period of performance: 6/3/2019 - 6/2/2020 (BASE)
Quick answers
Who was awarded contract 75N91019F00148?
75N91019F00148 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on June 3, 2019.
How much is contract 75N91019F00148 worth?
The government has obligated $500,563 on 75N91019F00148. Its potential value, with all options, is $505,563.
Is contract 75N91019F00148 an order under another contract?
Yes. 75N91019F00148 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Scientific Equipment and Services (FSS-66).
Was contract 75N91019F00148 competed?
The extent of competition for 75N91019F00148 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award